Skip to content
10-Q

Quarterly Report

Faeth Therapeutics, Inc. FTH SNSE

0001193125-25-281590

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 1.26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.26M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.26M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 1.25M sh
Capex Q3 2025 · Sep 30, 2025 $16K
Capex Q3 2025 · Sep 30, 2024 $146K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.59M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$18.88M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $10.56M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $9.99M
Stockholders Equity Q3 2025 · Sep 30, 2025 $23.01M
Stockholders Equity Q3 2025 · Jun 30, 2025 $27.31M
Stockholders Equity Q3 2025 · Mar 31, 2025 $31.99M
Stockholders Equity Q3 2025 · Dec 31, 2024 $38.39M
Stockholders Equity Q3 2025 · Sep 30, 2024 $45.78M
Stockholders Equity Q3 2025 · Jun 30, 2024 $52.19M
Stockholders Equity Q3 2025 · Mar 31, 2024 $58.47M
Stockholders Equity Q3 2025 · Dec 31, 2023 $64.9M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.44M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.45M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.58M
Total Liabilities Q3 2025 · Dec 31, 2024 $6.98M
Current Assets Q3 2025 · Sep 30, 2025 $25.79M
Current Assets Q3 2025 · Dec 31, 2024 $41.93M
Total Assets Q3 2025 · Sep 30, 2025 $27.59M
Total Assets Q3 2025 · Dec 31, 2024 $45.36M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.62
Eps Diluted Q3 2025 · Sep 30, 2025 −$12.98
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.77
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$17.84
Eps Basic Q3 2025 · Sep 30, 2025 −$3.62
Eps Basic Q3 2025 · Sep 30, 2025 −$12.98
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.77
Eps Basic restated Q3 2025 · Sep 30, 2024 −$17.84
Sga Expense Q3 2025 · Sep 30, 2025 $2.32M
Sga Expense Q3 2025 · Sep 30, 2025 $8.54M
Sga Expense Q3 2025 · Sep 30, 2024 $3.19M
Sga Expense Q3 2025 · Sep 30, 2024 $10.2M
Net Income Q3 2025 · Sep 30, 2025 −$4.57M
Net Income Q3 2025 · Sep 30, 2025 −$16.37M
Net Income Q3 2025 · Jun 30, 2025 −$4.94M
Net Income Q3 2025 · Mar 31, 2025 −$6.86M
Net Income Q3 2025 · Sep 30, 2024 −$7.25M
Net Income Q3 2025 · Sep 30, 2024 −$22.39M
Net Income Q3 2025 · Jun 30, 2024 −$7.14M
Net Income Q3 2025 · Mar 31, 2024 −$7.99M
Operating Income Q3 2025 · Sep 30, 2025 −$4.85M
Operating Income Q3 2025 · Sep 30, 2025 −$17.33M
Operating Income Q3 2025 · Sep 30, 2024 −$7.82M
Operating Income Q3 2025 · Sep 30, 2024 −$24.34M